News Releases

August 24, 2020
DURHAM, NC – August 24, 2020 – Bioventus , a global leader in orthobiologic solutions, has appointed Katrina Church as its Chief Compliance Officer, effective August 24, 2020. Church brings more than 20 years of experience counseling public and private companies to ensure the highest compliance
June 15, 2020
HOOFDDORP, THE NETHERLANDS – June 15, 2020 – Bioventus , a global leader in orthobiologic solutions, has selected Bazis NN as its authorized distributor for DUROLANE , its single-injection joint-fluid osteoarthritis (OA) treatment. OA involves the breakdown, or degeneration, of cartilage and the
February 24, 2020
DURHAM, NC – February 24, 2020 – Bioventus , a global leader in orthobiologic solutions, is recognizing 25 years of proven bone healing with its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and
February 10, 2020
DURHAM, NC – February 10, 2020 – Bioventus , a global leader in orthobiologic solutions, has updated the indications for use for its EXOGEN Ultrasound Bone Healing System . EXOGEN uses low-intensity pulsed ultrasound (LIPUS) to help stimulate the body’s natural bone healing process and promote
December 18, 2019
DURHAM, NC – December 18, 2019 – Beginning January 1, 2020 Bioventus , a global leader in orthobiologic solutions, has secured preferred access for Blue Cross Blue Shield of Michigan Medicare Advantage and Commercial patients to DUROLANE , GELSYN-3 and SUPARTZ FX to treat knee osteoarthritis (OA)
October 10, 2019
DURHAM, NC – October 10, 2019 – In support of World Arthritis Day, which is celebrated every October 12 to raise awareness of arthritis, Bioventus , a global leader in orthobiologics, has launched a disease and product information website called OAKneePainRelief.com which combines information on
Displaying 31 - 40 of 55